xenetix 300 mg/ml raztopina za injiciranje
guerbet - jod - raztopina za injiciranje - jod 300 mg / 1 ml - jobitridol
xenetix 300 mg/ml raztopina za injiciranje
guerbet - jod - raztopina za injiciranje - jod 300 mg / 1 ml - jobitridol
xenetix 350 mg/ml raztopina za injiciranje
guerbet - jod - raztopina za injiciranje - jod 350 mg / 1 ml - jobitridol
xenetix 350 mg/ml raztopina za injiciranje
emporio medical d.o.o. - jod - raztopina za injiciranje - jod 350 mg / 1 ml - jobitridol
xenetix 300 mg/ml raztopina za injiciranje
emporio medical d.o.o. - jod - raztopina za injiciranje - jod 300 mg / 1 ml - jobitridol
xenetix 300 mg/ml raztopina za injiciranje
emporio medical d.o.o. - jod - raztopina za injiciranje - jod 300 mg / 1 ml - jobitridol
xenetix 350 mg/ml raztopina za injiciranje
guerbet - jod - raztopina za injiciranje - jod 350 mg / 1 ml - jobitridol
xenetix 350 mg/ml raztopina za injiciranje
guerbet - jod - raztopina za injiciranje - jod 350 mg / 1 ml - jobitridol
abrysvo
pfizer europe ma eeig - respiratory syncytial virus, subgroup a, stabilized prefusion f protein / respiratory syncytial virus, subgroup b, stabilized prefusion f protein - infekcije respiratornih sincicijskih virusov - cepiva - abrysvo is indicated for:passive protection against lower respiratory tract disease caused by respiratory syncytial virus (rsv) in infants from birth through 6 months of age following maternal immunisation during pregnancy. glej poglavja 4. 2 in 5. active immunisation of individuals 60 years of age and older for the prevention of lower respiratory tract disease caused by rsv. uporaba tega cepiva mora biti v skladu z uradnimi priporočili.
hypotears 10 mg/g gel za oko
laboratoires thea - vitamin a - gel za oko - vitamin a 10 mg / 1 g - umetne solze in druga nevtralna zdravila